Perrigo Co. Plc (PRGO)
14.66
+0.02
(+0.14%)
USD |
NYSE |
Sep 01, 11:11
Perrigo Cash from Operations (TTM) : 196.10M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 196.10M |
| March 31, 2026 | 189.40M |
| December 31, 2025 | 238.50M |
| September 30, 2025 | 375.70M |
| June 30, 2025 | 366.20M |
| March 31, 2025 | 299.80M |
| December 31, 2024 | 362.90M |
| September 30, 2024 | 259.00M |
| June 30, 2024 | 341.30M |
| March 31, 2024 | 384.70M |
| December 31, 2023 | 405.50M |
| September 30, 2023 | 382.70M |
| June 30, 2023 | 317.40M |
| March 31, 2023 | 247.60M |
| December 31, 2022 | 307.30M |
| September 30, 2022 | 16.00M |
| June 30, 2022 | 300.60M |
| March 31, 2022 | 235.20M |
| December 31, 2021 | 156.30M |
| September 30, 2021 | 372.10M |
| June 30, 2021 | 91.40M |
| March 31, 2021 | 464.60M |
| December 31, 2020 | 636.20M |
| September 30, 2020 | 615.30M |
| June 30, 2020 | 692.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 465.10M |
| December 31, 2019 | 387.80M |
| September 30, 2019 | 492.60M |
| June 30, 2019 | 496.60M |
| March 31, 2019 | 515.10M |
| December 31, 2018 | 593.00M |
| September 30, 2018 | 610.80M |
| June 30, 2018 | 663.50M |
| March 31, 2018 | 672.40M |
| December 31, 2017 | 694.10M |
| September 30, 2017 | 688.20M |
| June 30, 2017 | 710.50M |
| March 31, 2017 | 750.50M |
| December 31, 2016 | 654.90M |
| September 30, 2016 | 154.50M |
| June 30, 2016 | -10.50M |
| March 31, 2016 | 241.50M |
| December 31, 2015 | 323.20M |
| September 30, 2015 | 910.10M |
| June 30, 2015 | 1.037B |
| March 31, 2015 | 799.80M |
| June 30, 2014 | 693.50M |
| March 31, 2014 | 574.49M |
| December 31, 2013 | 544.50M |
| September 30, 2013 | 582.84M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 37.01M |
| Jazz Pharmaceuticals Plc | 1.661B |
| GH Research Plc | -52.32M |
| Cosmo NV | -23.86M |
| Viatris, Inc. | 2.331B |